| Thursday, 01 March 2007 | ||
|
Figure: Bladder afferent neurons in L6 DRG exhibiting de novo expression of MCP-1/CCL2 (left panel) and CCR-2(right panel) in rats that underwent sciatic nerve injury, but not in sham-treated control rats (insets).
Result: CTB-555 positive bladder afferents were present in T13-L2 and L6-S2 DRGs. Many CTB-555-positive neurons in those ganglia also exhibited de novo expression of MCP-1/CCL2 and to a lesser degree, the chemokine receptor CCR2, following sciatic nerve injury (Figure). No such expression of chemokines was seen in control rats that underwent retrograde labeling of bladder afferents but did not undergo sciatic nerve injury. Conclusions: In an animal model, sciatic nerve injury has been shown to produce neuronal phenotype changes in both the somatic primary afferent neurons in the DRGs directly impacted by the somatic injury and also in adjacent, uninjured visceral primary afferent neurons affiliated with the bladder. As MCP-1/CCR2 signaling is known to influence excitability of sensory neurons and neuropathic pain behavior; upregulation of this ligand/receptor pairing may impact visceral sensory neurons in a similar fashion and contribute to the symptomatology of PBS/IC.
UroToday.com Coverage of SUFU 2007
Please log-in or register in order to submit comments. Powered by AkoComment! |
||
| < Prev | Next > |
|---|
|
UroToday, 1802 Fifth Street, Berkeley CA 94710 510.540.0930 (fax), info@urotoday.com ISSN 1939-4810
Privacy Policy | © 2008 UroToday ® All Rights Reserved |








